Tools commonly used in the Pathologists industry for day-to-day tasks and operations.

• Microscopes
• Autopsy saws
• Tissue processors
• Cryostats
• Immunohistochemistry staining systems
• Flow cytometers
• Digital imaging systems
• Polymerase chain reaction (PCR) machines
• Spectrophotometers
• Liquid chromatography-mass spectrometry (LC-MS) systems

Common products and services typical of NAICS Code 621111-06, illustrating the main business activities and contributions to the market.

• Cancer diagnosis
• Infectious disease testing
• Forensic pathology
• Genetic testing
• Hematology analysis
• Immunology testing
• Toxicology testing
• Blood bank services
• Clinical trials
• Research and development

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• American Board Of Pathology Certification: This certification is required for pathologists in the US. It is a board certification that ensures that the pathologist has the necessary knowledge and skills to practice pathology. The certification is provided by the American Board of Pathology.
• Clinical Laboratory Improvement Amendments (CLIA) Certification: This certification is required for laboratories that perform testing on human specimens for the purpose of diagnosis, prevention, or treatment of disease. Pathology laboratories are required to have this certification. The certification is provided by the Centers for Medicare & Medicaid Services.
• State Medical License: Pathologists are required to have a medical license to practice medicine in the US. The license is provided by the state medical board where the pathologist practices. The requirements for the license vary by state.
• Diplomate Of the American Board Of Medical Microbiology (ABMM): This certification is for pathologists who specialize in medical microbiology. It is a board certification that ensures that the pathologist has the necessary knowledge and skills to practice medical microbiology. The certification is provided by the American Board of Medical Microbiology.
• Diplomate Of the American Board Of Clinical Chemistry (ABCC): This certification is for pathologists who specialize in clinical chemistry. It is a board certification that ensures that the pathologist has the necessary knowledge and skills to practice clinical chemistry. The certification is provided by the American Board of Clinical Chemistry.

A concise historical narrative of NAICS Code 621111-06 covering global milestones and recent developments within the United States.

• Pathology is the study of disease and its causes, processes, development, and consequences. The field of pathology has a long and rich history, dating back to ancient times when physicians first began to study the human body and its functions. In the 19th century, the development of the microscope allowed for more detailed study of tissues and cells, leading to the emergence of modern pathology. In the early 20th century, the discovery of blood typing and the use of X-rays and other imaging techniques further advanced the field. In recent years, advances in genetics and molecular biology have revolutionized the study of pathology, allowing for more precise diagnosis and treatment of diseases. In the United States, the field of pathology has a rich history dating back to the early 20th century. In 1922, the American Society of Clinical Pathologists was founded, followed by the American Board of Pathology in 1936. In the 1950s and 1960s, the development of new technologies such as electron microscopy and immunohistochemistry further advanced the field. In the 21st century, the use of digital pathology and artificial intelligence has transformed the way pathologists work, allowing for faster and more accurate diagnosis of diseases. Overall, the field of pathology continues to evolve and adapt to new technologies and discoveries, playing a critical role in the diagnosis and treatment of diseases.

The anticipated future trajectory of the NAICS 621111-06 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Stable

  According to a report by ResearchAndMarkets.com, the global anatomic pathology market, which includes the industry of Pathologists, is expected to grow at a CAGR of 6.1% from 2020 to 2027. The increasing prevalence of chronic diseases, such as cancer, and the growing demand for personalized medicine are some of the factors driving the growth of the market. Additionally, the increasing adoption of digital pathology and the development of advanced diagnostic techniques are expected to further boost the growth of the industry in the USA.

Recent groundbreaking advancements and milestones in the Pathologists industry, reflecting notable innovations that have reshaped its landscape.

• Digital Pathology: The adoption of digital pathology has revolutionized the industry of Pathologists. It allows for the digitization of slides, which can be easily shared and accessed remotely, improving the efficiency and accuracy of diagnoses.
• Liquid Biopsy: This is a non-invasive diagnostic technique that involves the analysis of blood samples to detect cancer cells or DNA fragments. It has the potential to replace traditional biopsies, which are invasive and can be risky for patients.
• Artificial Intelligence: The use of AI in pathology has shown promising results in improving the accuracy and speed of diagnoses. It can analyze large amounts of data and identify patterns that may not be visible to the human eye.
• Next-Generation Sequencing: This is a technique that allows for the analysis of DNA and RNA at a much faster and cheaper rate than traditional sequencing methods. It has the potential to revolutionize cancer diagnosis and treatment.
• Telepathology: This is the practice of using telecommunication technology to transmit pathology images and data for diagnosis, consultation, and education. It allows for remote access to pathology services, particularly in rural or underserved areas.